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Abstract
Background: Cow’s milk allergy is one of the most common food allergies among younger children. We
investigated IgE antibodies to milk, and IgE and IgG4 antibodies to casein, a-lactalbumin and b-lactoglobulin in
cow’s milk allergic (CMA) and non-allergic (non-CMA) children in order to study their clinical usefulness.
Methods: Eighty-three children with suspected milk allergy (median age: 3.5 years, range: 0.8-15.8 years) were
diagnosed as CMA (n = 61) or non-CMA (n = 22) based on an open milk challenge or convincing clinical history.
Their serum concentrations of allergen-specific (s) IgE and IgG4 antibodies were measured using ImmunoCAP®. For
the sIgG4 analysis, 28 atopic and 31 non-atopic control children were additionally included (all non-milk sensitized).
Results: The CMA group had significantly higher levels of milk-, casein- and b-lactoglobulin-sIgE antibodies as
compared to the non-CMA group. The casein test showed the best discriminating performance with a clinical
decision point of 6.6 kUA/L corresponding to 100% specificity. All but one of the CMA children aged > 5 years had
casein-sIgE levels > 6.6 kUA/L. The non-CMA group had significantly higher sIgG4 levels against all three milk
allergens compared to the CMA group. This was most pronounced for casein-sIgG4 in non-CMA children without
history of previous milk allergy. These children had significantly higher casein-sIgG4 levels compared to any other
group, including the non-milk sensitized control children.
Conclusions: High levels of casein-sIgE antibodies are strongly associated with milk allergy in children and might
be associated with prolonged allergy. Elevated casein-sIgG4 levels in milk-sensitized individuals on normal diet
indicate a modified Th2 response. However, the protective role of IgG4 antibodies in milk allergy is unclear.
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Background
Food allergies, described as adverse immune responses
to food, are common and have increased in prevalence
during the past decades. About 5% of the young chil-
dren and 3-4% of the adults are affected today [1]. Milk,
egg, peanut, tree nuts, fish, shellfish, wheat and soy are
considered to cause most of the food adverse reactions
[1]. Of these, cow’s milk is the most frequent food caus-
ing allergy among infants and young children with a
prevalence ranging from 1 to about 7.5% [2,3]. Proper
management of milk allergy is important due to the low
but serious risk of anaphylaxis [4]. Fortunately most
children recover spontaneously from their allergy and
develop tolerance to cow’s milk until they reach 5 years
of age [5,6]. The remaining children may have a pro-
longed cow’s milk allergy causing discomfort and limita-
tions to their daily lives for many years [7]. A recent
study indicates that the proportion of children with pro-
longed milk allergy might be larger than previously
anticipated [8].
The most important allergens in cow’s milk are a-lac-
talbumin (also called Bos d 4), b-lactoglobulin (Bos d 5)
and casein (Bos d 8) [2,9]. Milk can be separated into
two fractions, the whey and the coagulum. Most known
milk allergens are found in the milk whey including a-
lactalbumin and b-lactoglobulin, while casein is present
in the coagulum. Casein has been shown to be both
more antigenic and allergenic than the whey proteins
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indicating its role as important milk allergen [10]. How-
ever, all milk proteins appear to be potential allergens
and patients are often sensitized to several of them [11].
It has been shown that patients that are sensitized to
several milk allergens tends to have a poor prognosis
regarding outgrown of their milk allergy [12].
Diagnosis and management of food allergy include
steps like initial avoidance of the suspected food aller-
gen, skin prick testing and measuring of serum levels of
food-specific IgE antibodies mostly using extract-based
tests. In time, in order to confirm the diagnosis or to
determine whether a reintroduction of the particular
food is safe due to tolerance development, oral food
challenges could be conducted [4]. Other diagnostic
tools making it possible to earlier discriminate between
prolonged and tolerated food allergies are desirable. We
have earlier shown in wheat and egg allergy that specific
IgE measurements could help the physician to provide
better guidance to their patients and be a complement
to food challenges [13,14].
Here, in order to study the clinical usefulness of speci-
fic antibodies in milk allergy, the concentrations of IgE
antibodies to milk, and IgE and IgG4 antibodies to
casein, a-lactalbumin and b-lactoglobulin were studied
in sera from milk allergic and milk tolerant children.
Methods
Subjects
Eighty-three children with a suspected IgE-mediated
cow’s milk allergy (CMA) were enrolled in the study. The
patients (male/female ratio, 55/28) ranged in age from
0.8 to 15.8 years (median: 3.5 years). All were milk sensi-
tized as revealed by specific IgE in vitro test (n = 81), or
had a history of positive skin prick test to milk (n = 2).
Most of them suffered from atopic dermatitis (85%) and
some also from asthma (32%). The patients were divided
into two groups on the basis of their immediate reactions
to an open oral milk provocation challenge test or
through their case history. The cow ’s milk allergic
(CMA) group (n = 61) had either a positive challenge
result for milk (n = 34) or a convincing history of present
milk allergy making a challenge test redundant (n = 27).
The non-CMA group (n = 22) contained children who
had no allergic reactions to milk at the time of examina-
tion. A subgroup of them had obtained tolerance after a
previous diagnosed milk allergy (Tolerant, n = 11) which
was verified with a negative challenge test with milk. The
remaining children had never had a milk allergy diagnosis
(Negative, n = 11). Further details about the study groups
are found in Table 1.
For the specific IgG4 analyses, a non-milk sensitized
control group was included consisting of children that
consulted our allergy clinic due to eczema, urticaria,
bronchial asthma or any suspicion of allergic diseases
and were examined for the following specific IgE antibo-
dies; milk, Dermatophagoides pteronyssinus, cat dander,
egg white, wheat, orchard grass, and Japanese cedar.
Those who had no clinical history of milk allergy and
without milk-specific IgE antibodies (< 0.35 kUA/L)
were selected, and subsequently divided into the follow-
ing two subgroups. One subgroup consisted of 31 non-
atopic controls (NAC; median age: 1.0 years, range: 0.8-
6 years). They had low total IgE levels (median: 13.0
kU/L, range: 2.0-29.0 kU/L) and were negative to all of
the specific IgE antibodies examined. The other sub-
group consisted of 28 atopic controls (AC; median age:
Table 1 Patient characteristics of cow’s milk allergic (CMA) children, diagnosed by food challenge (Challenge) or a
convincing history of present milk allergy (History), and non-CMA children sensitized to milk.
CMA (n = 61) non-CMA (n = 22)
Challenge History Tolerant Negative
Sex (boys/girls) 21/13 18/9 7/4 9/2
Age, years (median, range) 3.9 (1.0-12.7) 3.0 (0.8-12.8) 2.5 (1.0-15.8) 3.2 (1.4-14.2)
Serology (median, range)
Total IgE (kU/L) 395 (32.0-12,784) 536 (34.0-14,283) 267 (44.0-3,260) 958 (66.1-27,815)
Milk-sIgE (kUA/L) 11.6 (< 0.35- > 100) 15.9 (1.4- > 100) 4.2 (< 0.35-27.6) 3.9 (1.0-17.3)
Casein-sIgE (kUA/L) 13.0 (< 0.35- > 100) 21.6 (0.42- > 100) 2.3 (< 0.35-6.6) 2.0 (1.1-4.2)
Allergic symptoms, no (%)
Atopic dermatitis 28 (82%) 24 (89%) 9 (82%) 10 (91%)
Asthma 9 (26%) 12 (44%) 5 (45%) 1 (9%)
Egg allergy 25 (74%) 20 (74%) 4 (36%) 6 (54%)
Medication, no (%)
H1-antagonist 6 (18%) 6 (22%) 3 (27%) 3 (27%)
Inhaled corticosteroids 2 (6%) 5 (18%) - -
The latter group consisted of a subgroup of children that had obtained tolerance after a previous diagnosis of milk allergy (Tolerant) and subgroup of children
that never had had a milk allergy diagnosis (Negative).
For details see method section.
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5.0 years, range: 1-15 years). They were sensitized to at
least one of the allergens described above, except milk,
and had a median total IgE level of 928 kU/L (range:
254-4,618 kU/L).
Informed consent was obtained from patients, their
parents, or both. The study was approved by the Ethics
Committee of Fujita Health University School of
Medicine.
Oral milk challenge
Open oral milk provocation tests were carried out as
described in a Japanese guideline [15]. The children
were orally challenged with raw milk, starting with one
drop and followed with increasing volumes (1, 2, 5, 10,
20 or 30 ml) every 20 minutes, until a reaction was
observed. Only objective immediate reactions were con-
sidered as positive results and the patients were given
relevant relief medication thereafter. All provocation
tests were conducted by qualified medical personnel.
Serological analysis
Serum levels of total IgE, IgE antibodies to milk, casein,
a-lactalbumin and b-lactoglobulin, and IgG4 antibodies
to casein, a-lactalbumin and b-lactoglobulin were mea-
sured using ImmunoCAP® (Phadia AB, Uppsala, Swe-
den). The commercially available tests and reagents
were used according to the instructions from the
manufacturer.
Statistical analysis
The Mann-Whitney U-test (two-tailed) was used for
comparisons between the groups and p values < 0.05
were considered significant. Receiver operating
characteristic (ROC) analysis was performed for the dif-
ferent milk allergen ImmunoCAP tests used for specific
IgE measurement [16]. Before statistical evaluation, all
specific IgE values below the assay cut off (0.35 kUA/L)
were assigned a value of 0.34 kUA/L, and all values
above 100 kUA/L (higher limit of quantitation) were
assigned a value of 101 kUA/L. In the same way, all spe-
cific IgG4 levels below the assay cut off (0.07 mgA/L)
were assigned a value of 0.06 mgA/L.
Results
Milk allergen-specific IgE antibodies
No significant differences in total IgE levels between the
CMA and non-CMA groups were seen (Table 1), while
the CMA group had significant higher levels of milk-
specific IgE antibodies as compared to the non-CMA
group (Figure 1). Two children were negative for milk-
specific serum IgE antibodies (< 0.35 kUA/L), but had a
history of positive skin prick tests with wheal diameters
of 12 × 4 and 15 × 9 mm, respectively.
The CMA patients had increased levels of casein-spe-
cific IgE antibodies as compared to the non-CMA
patients. All but one CMA patient had casein-specific
IgE > 0.35 kUA/L resulting in a 98% sensitivity for the
casein ImmunoCAP test using the traditional assay cut
off. The levels of b-lactoglobulin-specific IgE were also
increased in the CMA group, but no differences
between the groups were seen for a-lactalbumin-specific
IgE. There were 19 patients without measurable b-lacto-
globulin-specific IgE (< 0.35 kUA/L) and 30 patients
without a-lactalbumin-specific IgE, resulting in clinical
sensitivity values of 69% for the b-lactoglobulin test and
51% for the a-lactalbumin test, respectively (Figure 1).

















Figure 1 Serum concentration of milk allergen-specific IgE antibodies in children with cow’s milk allergy (CMA) and with tolerance to
milk (non-CMA). The median levels are shown as indicated. * p < 0.05, *** p < 0.001.
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The ROC analysis showed that the casein Immuno-
CAP test was superior in its diagnostic performance
compared to the milk, a-lactalbumin and b-lactoglobu-
lin tests (Figure 2). It was especially outstanding in its
clinical specificity. The ROC analysis for the casein
ImmunoCAP test showed that, when using a clinical
decision point corresponding to 6.6 kUA/L of casein-
specific IgE, a specificity of 100% and a sensitivity of
72% could be achieved. At corresponding cut-off points
with 100% clinical specificity, the milk and b-lactoglobu-
lin tests showed clinical sensitivity values of just 33%
and 11%, respectively. Using the a-lactalbumin Immu-
noCAP test, a specificity of no better than 63% could be
achieved in this patient material. No children with
casein-specific IgE below the clinical decision point of
6.6 kUA/L had high levels of IgE antibodies to milk, b-
lactoglobulin or a-lactalbumin.
Tolerance for cow’s milk is expected to be obtained
until the age of five years for most allergic children
[5,6]. When looking at the subgroup of children over
five years of age, all but one of the CMA children had
casein-specific IgE concentrations above our suggested
positive prediction point of 6.6 kUA/L, while all of the
older non-CMA children had lower levels (Figure 3).
Also the IgE levels to milk and b-lactoglobulin were sig-
nificantly elevated in CMA children compared to non-
CMA children over five years of age, although not as prominent as for the casein-specific IgE (data not
shown).
Milk allergen-specific IgG4 antibodies
The serum levels of casein-, a-lactalbumin- and b-lacto-
globulin-specific IgG4 antibodies were measured in the
CMA and non-CMA groups as well as in a non-milk
sensitized control group consisting of children with (AC
subgroup) and without atopy (NAC subgroup) as
defined by their sensitization to common inhalant and/
or food allergens.
The non-CMA group had significantly increased levels
of specific IgG4 antibodies to all three milk allergens as
compared to the CMA group (p < 0.01 and < 0.001).
However, when studying the Tolerant and Negative sub-
groups of the non-CMA group individually, it was
shown that the increased levels of specific IgG4 were
seen mainly in the Negative subgroup composed of chil-
dren without previous history of milk allergy (Table 2).
Increased levels of specific IgG4 to a-lactalbumin- and
b-lactoglobulin were also seen in the non-milk sensi-
tized control group. However, increased levels of casein-
specific IgG4 antibodies, as compared to the CMA
group, were only found in the AC subgroup (Table 2).
The overall highest levels of casein-specific IgG4 were
observed in the Negative subgroup of children belonging
to the non-CMA group followed in rank by the AC sub-
group (p < 0.05) and the NAC subgroup (p < 0.001).
ROC curves

















Figure 2 ROC curves showing the performance of the
ImmunoCAP tests for milk-, casein-, a-lactalbumin- and b-
lactoglobulin-specific IgE antibodies in relation to the
diagnosis of cow’s milk allergy.


















Figure 3 Serum concentrations of casein-specific IgE
antibodies in children aged > 5 years with cow’s milk allergy
(CMA) and with tolerance to milk (non-CMA). The median levels
are shown as indicated. *** p < 0.001.
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The casein-specific IgG4 levels in the NAC subgroup
were similar as in the CMA group and the Tolerant
subgroup.
Discussion
In the present study, it was shown that the levels of IgE
antibodies to milk, casein and b-lactoglobulin were
increased in Japanese children with milk allergy com-
pared to milk-sensitized children without present symp-
toms to milk (non-CMA children). When comparing
different ImmunoCAP tests for measurement of IgE
antibodies to milk, casein, a-lactalbumin and b-lactoglo-
bulin, the best performance in the diagnosis of milk
allergy was shown for the casein test. All but one of the
CMA children had casein-specific IgE antibodies (> 0.35
kUA/L). A majority of them (72%) had casein-specific
IgE antibodies above our suggested clinical decision
point of 6.6 kUA/L, while all non-CMA children were
below this cut-off point for casein-specific IgE.
Milk allergy is an obvious health problem and burden
for the individual allergic child. But the disease also
causes limitations to the daily life of the immediate
family in their effort of trying to avoid accidental expo-
sure of their child to milk. A recent study showed that
allergic reactions to accidental exposure to milk aller-
gens indeed are frequent [17]. Avoiding casein and
other cow’s milk allergens might not always be so sim-
ple or feasible considering that all kinds of foods and
dairy products may not have the proper labeling of the
contents. Allergic reactions have also been reported as a
result of casein being added as an extender to non-dairy
products such as sausages and soups [18].
Double-blind, placebo-controlled food challenge is
considered to be the gold standard for food allergy
diagnosis, although it carries some risks for the patient
and is time-consuming to conduct [15]. For several
reasons many children are diagnosed as having a food
allergy even though no food challenges are performed
[4]. This may lead to an over-diagnosis that is very
costly for the society. Even more important, it is
negatively influencing the quality of life for the whole
family that is concerned [19]. Serious food allergies
may also be missed. Therefore, improved diagnostic
tools including better knowledge how to interpret test
results are crucial. For several years studies have been
performed by leading allergologists to find clinical
decision points for the diagnosis of food allergy using
allergen-specific serum IgE measurements. Cut-off
points for clinical milk allergy in 2-3 year old children
have been reported by others to be 24 kUA/L for IgE
antibodies to milk and 9 kUA/L for IgE to casein,
respectively [20]. Thus, a similar decision point for the
casein-specific IgE as found in the present study with
Japanese children with a median age of 3.5 years. How-
ever, clinical decision points often varies between stu-
dies which can be explained by differences between the
study populations and the statistical criteria for choos-
ing the decision points [21]. For example, younger
children generally have lower levels of IgE antibodies
to milk compared to older children [20,22], something
that has to be acknowledged when interpreting specific
IgE test results in the diagnosis of children.
Studies have shown that milk-specific IgE levels are
lower in children who later become tolerant than in
those with prolonged allergy, showing that IgE antibody
measurements can be used to predict tolerance develop-
ment [8,23,24]. In our study, the levels of specific IgE to
milk, casein and b-lactoglobulin were elevated in
patients diagnosed with prolonged milk allergy (defined
as having milk allergy at age > 5 years) as compared to
milk-tolerant patients at similar age. Again, the casein
test showed an excellent diagnostic performance, since
all but one of the CMA children had casein-specific IgE
levels above our suggested positive prediction point of
6.6 kUA/L. Also others have shown that patients with
prolonged milk allergy generally have higher levels of
milk-specific IgE than patients whose allergy has
resolved [7,8], and the association between casein-speci-
fic IgE and prolonged milk allergy has been shown both
in children [20,23] and in adults [25].
Table 2 Levels of milk allergen-specific IgG4 antibodies.
Test CMA group Non-CMA group Non-milk sensitized control group
Tolerant Negative AC NAC
n = 61 n = 11 n = 11 n = 28 n = 31
Casein 0.36 (< 0.07-13.4) 0.46 (< 0.07-25.4) 24.8 (0.17-197) 5.2 (0.14-64.7) 1.3 (< 0.07-125)
p-value - NS < 0.001 < 0.001 NS
a-lactalbumin < 0.07 (< 0.07-2.7) < 0.07 (< 0.07-1.8) 7.1 (0.09-52.9) 2.0 (< 0.07-44.7) 1.2 (< 0.07-25.1)
p-value - NS < 0.001 < 0.001 < 0.01
b-lactoglobulin < 0.07 (< 0.07-3.5) 0.09 (< 0.07-1.8) 5.2 (< 0.07-16.5) 1.5 (< 0.07-20.6) 0.53 (< 0.07-28.2)
p-value - NS < 0.001 < 0.001 < 0.001
Results are presented as median concentrations (mgA/L) with range.
For details about the different groups/subgroups, see method section. Significant differences compared to the CMA group are shown by the p-value. NS
indicates non-significant difference.
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The production of IgG4 antibodies is considered to be
a normal physiological response to the ingestion of
cow’s milk [26]. Previous studies have shown that indivi-
duals that tolerate cow’s milk have higher levels of milk-
specific IgG4 antibodies than those with a prolonged
milk allergy [27,28], and it has been indicated that IgE
and IgG4 antibodies combined might be used to predict
tolerance development [29]. However, in our study the
subgroup of non-CMA children who had obtained milk
tolerance as diagnosed by challenge (Tolerant group)
did not have significantly higher levels of casein-, a-lac-
talbumin- or b-lactoglobulin-specific IgG4 antibodies as
compared to the CMA group, probably a consequence
of their milk avoidance. Instead, the subgroup of chil-
dren who never had had milk allergy, although sensi-
tized to milk (Negative subgroup), showed elevated
concentrations of IgG4 antibodies. This indicates that
high levels of milk allergen-specific IgG4 antibodies are
merely a reflection of a child’s diet where cow’s milk
normally is included. So in line with the common opi-
nion [30], our study supports that measurement of IgG4
antibodies has currently no role in the diagnosis of food
allergy.
Interestingly, the Negative subgroup had the highest
levels of casein-specific IgG4 of all groups in the study
including the AC group and NAC group with non-milk
sensitized children. It suggests that casein-specific IgG4
antibodies might be markers of a so-called modified
Th2 response as suggested by Platts-Mills [31]. Thus,
the milk allergen-specific IgG4 antibodies might have a
protective role against the development of milk allergy,
perhaps by blocking the antigen-presentation to aller-
gen-specific T cells as described by others [32].
Conclusions
IgE antibody levels to milk, casein and b-lactoglobulin
were increased in Japanese children with cow’s milk
allergy. The casein ImmunoCAP test showed the best
clinical performance. A majority of the CMA children
had casein-specific IgE levels above our suggested
positive decision point of 6.6 kUA/L, while all non-
CMA children were below this cut-off point. It was
also shown that the levels of casein-specific IgE
remained high in CMA children also after five years of
age. We therefore conclude that high levels of casein-
specific IgE antibodies are strongly associated with
milk allergy in children and might be associated with
a prolonged allergy. Results from the present study
indicate that high levels of casein-specific IgG4 antibo-
dies are associated with tolerance in milk-sensitized
children, but only in subjects on normal milk-contain-
ing diet. The protective role of IgG4 antibodies in a
so-called modified Th2 response is unclear, and it has
not yet been proven that measurement of IgG4
antibodies has a role in the clinical management of
food allergy. Thus, more studies are needed before
proposing routine use of specific IgG4 measurements
in milk allergy.
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